Rani Therapeutics Reports Quarterly Results for Quarter Ended September 30
FORECAST CHANGESRECOMMENDATIONSThis summary was machine generated from LSEG data November 9 at 10:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact Refi…
Story updates
10:03:28 PM UTC
SquawkNews
Rani Therapeutics reported third-quarter 2026 contract revenue of $1.7 million and a net loss of $8.8 million. Cash, cash equivalents and marketable securities totaled $45.3 million at September 30, 2026, and the company expects to fund operations at least through the end of 2027. The company also…
FORECAST CHANGESRECOMMENDATIONSThis summary was machine generated from LSEG data November 9 at 10:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com.
For any other questions or feedback, contact Refi…